Correlation Between Biotechnology Portfolio and Hennessy Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Hennessy Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Hennessy Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Hennessy Technology Fund, you can compare the effects of market volatilities on Biotechnology Portfolio and Hennessy Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Hennessy Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Hennessy Technology.

Diversification Opportunities for Biotechnology Portfolio and Hennessy Technology

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Biotechnology and Hennessy is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Hennessy Technology Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hennessy Technology and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Hennessy Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hennessy Technology has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Hennessy Technology go up and down completely randomly.

Pair Corralation between Biotechnology Portfolio and Hennessy Technology

Assuming the 90 days horizon Biotechnology Portfolio Biotechnology is expected to under-perform the Hennessy Technology. In addition to that, Biotechnology Portfolio is 1.04 times more volatile than Hennessy Technology Fund. It trades about -0.1 of its total potential returns per unit of risk. Hennessy Technology Fund is currently generating about 0.02 per unit of volatility. If you would invest  2,261  in Hennessy Technology Fund on October 8, 2024 and sell it today you would earn a total of  34.00  from holding Hennessy Technology Fund or generate 1.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Portfolio Biotec  vs.  Hennessy Technology Fund

 Performance 
       Timeline  
Biotechnology Portfolio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Hennessy Technology 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Hennessy Technology Fund are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Hennessy Technology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Portfolio and Hennessy Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Portfolio and Hennessy Technology

The main advantage of trading using opposite Biotechnology Portfolio and Hennessy Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Hennessy Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hennessy Technology will offset losses from the drop in Hennessy Technology's long position.
The idea behind Biotechnology Portfolio Biotechnology and Hennessy Technology Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings